{"protocolSection": {"identificationModule": {"nctId": "NCT02224755", "orgStudyIdInfo": {"id": "TC03062014"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "MOMENTUM 3 IDE Clinical Study Protocol", "officialTitle": "Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3\u2122 IDE Clinical Study Protocol", "acronym": "HM3\u2122"}, "statusModule": {"statusVerifiedDate": "2022-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2014-09-02", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-09-28", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-03-26", "type": "ACTUAL"}, "studyFirstSubmitDate": "2014-08-21", "studyFirstSubmitQcDate": "2014-08-21", "studyFirstPostDateStruct": {"date": "2014-08-25", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-10-02", "resultsFirstSubmitQcDate": "2019-10-30", "resultsFirstPostDateStruct": {"date": "2019-11-20", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-06-23", "lastUpdatePostDateStruct": {"date": "2022-06-27", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}, "collaborators": [{"name": "Thoratec Corporation", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The objective of the study is to evaluate the safety and effectiveness of the HM3 LVAS by demonstrating non-inferiority to the HMII LVAS (HMII) when used for the treatment of advanced, refractory, left ventricular heart failure.", "detailedDescription": "The HM3 LVAS is intended to provide hemodynamic support in patients with advanced, refractory left ventricular heart failure; either for short term support, such as a bridge to cardiac transplantation (BTT) or myocardial recovery, or as long term support, such as destination therapy (DT). The HM3 is intended for use inside or outside the hospital."}, "conditionsModule": {"conditions": ["Advanced Refractory Left Ventricular Heart Failure"], "keywords": ["Heart Failure", "Left Ventricular Assist Device", "Ventricular Dysfunction", "Cardiomyopathy", "Heart Disease", "Cardiovascular Disease", "Heart-assist devices", "Thoratec Corporation"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 1028, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "HeartMate 3 LVAS (HM3 LVAS)", "type": "EXPERIMENTAL", "description": "Evaluation of the safety and effectiveness of the HeartMate 3 LVAS by demonstrating non-inferiority to the HMII LVAS (HMII) when used for the treatment of advanced, refractory, left ventricular heart failure.", "interventionNames": ["Device: HeartMate 3 LVAS"]}, {"label": "HeartMate II LVAS", "type": "ACTIVE_COMPARATOR", "description": "Evaluation of the safety and effectiveness of the HeartMate 3 LVAS by demonstrating non-inferiority to the HMII LVAS (HMII) when used for the treatment of advanced, refractory, left ventricular heart failure.", "interventionNames": ["Device: HeartMate II LVAS"]}], "interventions": [{"type": "DEVICE", "name": "HeartMate 3 LVAS", "description": "Implantation of HeartMate 3 LVAD to evaluate the safety and effectiveness of the HeartMate 3 LVAS by demonstrating non-inferiority to the HMII LVAS (HMII) when used for the treatment of advanced, refractory, left ventricular heart failure", "armGroupLabels": ["HeartMate 3 LVAS (HM3 LVAS)"]}, {"type": "DEVICE", "name": "HeartMate II LVAS", "description": "Implantation of the commercially approved HeartMate II LVAD which is the standard treatment for advanced heart failure", "armGroupLabels": ["HeartMate II LVAS"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Short Term Primary End Point", "description": "Survival at 6 months free of disabling stroke (Modified Rankin Score \\> 3) or reoperation to replace or remove a malfunctioning device", "timeFrame": "The first 294 randomized Subjects will be followed for 6 months or to outcome (transplant, explant, or death), whichever occurs first."}, {"measure": "Long Term Primary End Point", "description": "Survival at 2 years free of disabling stroke (Modified Rankin Score \\> 3) or reoperation to replace or remove a malfunctioning device", "timeFrame": "The first 366 randomized Subjects will be followed for 24 months or to outcome (transplant, explant, or death), whichever occurs first."}], "secondaryOutcomes": [{"measure": "Powered Secondary End Point: Pump Replacement at Two Years", "description": "In addition to powering the study on the primary endpoints for PMA approval, the study will pre-specify a powered secondary endpoint to evaluate incidence of pump replacements at 24 months. HeartMate II is the control.", "timeFrame": "As they occur up to 24 months or to Outcome, whichever occurs first"}, {"measure": "EuroQoL 5D-5L (EQ-5D-5L) Total Score", "description": "Quality of Life as measured by EuroQoL 5 Dimension-5 Level (EQ-5D-5L) total score. The EQ-5D-5L questionnaire has patients rate their quality of life across 5 categories of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scores from the 5 dimensions are summed for the total score which ranges from 5 to 25 with higher scores indicating more problems and a worse quality of life.", "timeFrame": "Baseline to 24 months"}, {"measure": "EuroQol-5D-5L Visual Analogue Scale", "description": "Quality of life as measured by the visual analogue scale from the EuroQol-5D-5L questionnaire. The patient rates their current state of health with the visual analogue scale. The scale ranges from 0 to 100. Higher scores indicate a better quality of life.", "timeFrame": "Baseline to 24 months"}, {"measure": "Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score", "description": "Quality of Life as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ). Scores range from 0 to 100. Higher scores indicate better quality of life and fewer heart failure symptoms.", "timeFrame": "Baseline to 24 months"}, {"measure": "Six Minute Walk Test", "description": "Functional status as measured by the Six Minute Walk Test. The Six Minute Walk Test measures the distance a patient is able to walk during 6 minutes without running or jogging.", "timeFrame": "Baseline to 24 months"}, {"measure": "New York Heart Association (NYHA) Classification", "description": "Functional status as measured by NYHA classification. NYHA class categorizes patients by the severity of their heart failure symptoms. As the class increases, the degree of symptoms is more severe indicating worse functional status. Class I indicates no limitation of physical activity. Class II indicates slight limitation of physical activity. Class IIIA indicates marked limitation of physical activity where less than ordinary physical activity causes fatigue, palpitation, dyspnea, or angina pain. Class IIIB indicates marked limitation of physical activity where mild physical activity causes fatigue, palpitation, dyspnea, or angina pain. Class IV indicates inability to carry on any physical activity without discomfort.", "timeFrame": "Baseline to 24 months"}, {"measure": "Rehospitalizations", "description": "Rate of all cause rehospitalization", "timeFrame": "From initial discharge to two years post-implant"}, {"measure": "Adverse Event Rates", "description": "Events-per-patient-year (EPPY) for anticipated adverse events as defined in the study protocol", "timeFrame": "Two years post-implant"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Subject or legal representative has signed Informed Consent Form (ICF)\n2. Age \u2265 18 years\n3. BSA \u2265 1.2 m2\n4. NYHA Class III with dyspnea upon mild physical activity, or NYHA Class IV\n5. LVEF \u2264 25%\n6. a) Inotrope dependent OR b) CI \\< 2.2 L/min/m2, while not on inotropes and subjects must also meet one of the following:\n\n   * On Optimal Medical Management (OMM), based on current heart failure practice guidelines for at least 45 out of the last 60 days and are failing to respond\n   * Advanced Heart Failure for at least 14 days AND dependent on intra-aortic balloon pump (IABP) for at least 7 days\n7. Females of child bearing age must agree to use adequate contraception\n\nExclusion Criteria:\n\n1. Etiology of heart failure (HF) due to or associated with uncorrected thyroid disease, obstructive cardiomyopathy, pericardial disease, amyloidosis or restrictive cardiomyopathy\n2. Technical obstacles which pose an inordinately high surgical risk, in the judgment of the investigator\n3. Existence of ongoing mechanical circulatory support (MCS) other than IABP\n4. Positive pregnancy test if of childbearing potential\n5. Presence of mechanical aortic valve that will not be either converted to a bioprosthesis or oversewn at the time of LVAD implant\n6. History of any organ transplant\n7. Platelet count \\< 100,000 x 103/L (\\< 100,000/ml)\n8. Psychiatric disease/disorder, irreversible cognitive dysfunction or psychosocial issues that are likely to impair compliance with the study protocol and LVAS management\n9. History of confirmed, untreated AAA \\> 5 cm in diameter within 6 months of enrollment\n10. Presence of an active, uncontrolled infection\n11. Intolerance to anticoagulant or antiplatelet therapies or any other peri/post-operative therapy the investigator will require based upon the patients' health status\n12. Presence of any one of the following risk factors for indications of severe end organ dysfunction or failure:\n\n    1. An INR \u2265 2.0 not due to anticoagulation therapy\n    2. Total bilirubin \\> 43 umol/L (2.5 mg/dl), shock liver, or biopsy proven liver cirrhosis\n    3. History of severe chronic obstructive pulmonary disease (COPD) defined by FEV1/FVC \\< 0.7, and FEV1 \\<50% predicted\n    4. Fixed pulmonary hypertension with a most recent PVR \u2265 8 Wood units that is unresponsive to pharmacologic intervention\n    5. History of stroke within 90 days prior to enrollment, or a history of cerebrovascular disease with significant (\\> 80%) uncorrected carotid stenosis\n    6. Serum creatinine \u2265 221 umol/L (2.5 mg/dl) or the need for chronic renal replacement therapy\n    7. Significant peripheral vascular disease (PVD) accompanied by rest pain or extremity ulceration\n13. Patient has moderate to severe aortic insufficiency without plans for correction during pump implant\n14. Pre albumin \\< 150 mg/L (15mg/dL) or Albumin \\< 30g/L (3 g/dL) (if only one available) ; pre albumin \\< 150 mg/L (15mg/dL) and Albumin \\< 30g/L (3 g/dL) (if both available)\n15. Planned Bi-VAD support prior to enrollment\n16. Patient has known hypo or hyper coagulable states such as disseminated intravascular coagulation and heparin induced thrombocytopenia\n17. Participation in any other clinical investigation that is likely to confound study results or affect the study\n18. Any condition other than HF that could limit survival to less than 24 months", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "100 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Daniel Crandall, PhD", "affiliation": "Abbott", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Baptist Health Medical Center - Little Rock", "city": "Little Rock", "state": "Arkansas", "zip": "72205", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "Cedars Sinai Medical Center", "city": "Beverly Hills", "state": "California", "zip": "90211", "country": "United States", "geoPoint": {"lat": 34.07362, "lon": -118.40036}}, {"facility": "University of California, San Diego", "city": "La Jolla", "state": "California", "zip": "92037", "country": "United States", "geoPoint": {"lat": 32.84727, "lon": -117.2742}}, {"facility": "Sutter Memorial Hospital", "city": "Sacramento", "state": "California", "zip": "95816", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "Sharp Memorial Hospital", "city": "San Diego", "state": "California", "zip": "92123", "country": "United States", "geoPoint": {"lat": 32.71533, "lon": -117.15726}}, {"facility": "California Pacific Medical Center", "city": "San Francisco", "state": "California", "zip": "94115", "country": "United States", "geoPoint": {"lat": 37.77493, "lon": -122.41942}}, {"facility": "Stanford University", "city": "Stanford", "state": "California", "zip": "94305", "country": "United States", "geoPoint": {"lat": 37.42411, "lon": -122.16608}}, {"facility": "University of Colorado Hospital", "city": "Aurora", "state": "Colorado", "zip": "80045", "country": "United States", "geoPoint": {"lat": 39.72943, "lon": -104.83192}}, {"facility": "Yale New Haven Hospital", "city": "New Haven", "state": "Connecticut", "zip": "06510", "country": "United States", "geoPoint": {"lat": 41.30815, "lon": -72.92816}}, {"facility": "MedStar Washington Hospital Center", "city": "Washington", "state": "District of Columbia", "zip": "20010", "country": "United States", "geoPoint": {"lat": 38.89511, "lon": -77.03637}}, {"facility": "Shands Hospital @ University of Florida", "city": "Gainesville", "state": "Florida", "zip": "32610", "country": "United States", "geoPoint": {"lat": 29.65163, "lon": -82.32483}}, {"facility": "Florida Hospital", "city": "Orlando", "state": "Florida", "zip": "32804", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "Tampa General Hospital", "city": "Tampa", "state": "Florida", "zip": "33606", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "Piedmont Heart Institute", "city": "Atlanta", "state": "Georgia", "zip": "30309", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Emory University Hospital", "city": "Atlanta", "state": "Georgia", "zip": "30322", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Northwestern Memorial Hospital", "city": "Chicago", "state": "Illinois", "zip": "60611", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "University of Chicago Medical Center", "city": "Chicago", "state": "Illinois", "zip": "60637", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Advocate Christ Medical Center", "city": "Oak Lawn", "state": "Illinois", "zip": "60453", "country": "United States", "geoPoint": {"lat": 41.71087, "lon": -87.75811}}, {"facility": "IU Health/Methodist Hospital", "city": "Indianapolis", "state": "Indiana", "zip": "46202", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "St. Vincent Hospital", "city": "Indianapolis", "state": "Indiana", "zip": "46260", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "University of Iowa Hospitals and Clinics", "city": "Iowa City", "state": "Iowa", "zip": "52242", "country": "United States", "geoPoint": {"lat": 41.66113, "lon": -91.53017}}, {"facility": "University of Kentucky - Saha Cardiovascular Research Center", "city": "Lexington", "state": "Kentucky", "zip": "40536", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "Jewish Hospital", "city": "Louisville", "state": "Kentucky", "zip": "40202", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"facility": "Ochsner Medical Center", "city": "New Orleans", "state": "Louisiana", "zip": "70121", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"facility": "Johns Hopkins Unversity Hospital", "city": "Baltimore", "state": "Maryland", "zip": "21287", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"facility": "Massachusetts General Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02214", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Brigham & Women's Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02215", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "University of Michigan", "city": "Ann Arbor", "state": "Michigan", "zip": "48109", "country": "United States", "geoPoint": {"lat": 42.27756, "lon": -83.74088}}, {"facility": "Henry Ford Hospital", "city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Spectrum Health Butterworth Hospital", "city": "Grand Rapids", "state": "Michigan", "zip": "49503", "country": "United States", "geoPoint": {"lat": 42.96336, "lon": -85.66809}}, {"facility": "Abbott Northwestern Hospital", "city": "Minneapolis", "state": "Minnesota", "zip": "55407", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "University of Minnesota Medical Center, Fairview", "city": "Minneapolis", "state": "Minnesota", "zip": "55455", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"facility": "Mayo Clinic Rochester", "city": "Rochester", "state": "Minnesota", "zip": "55905", "country": "United States", "geoPoint": {"lat": 44.02163, "lon": -92.4699}}, {"facility": "Barnes Jewish Hospital", "city": "Saint Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "University of Nebraska Medical Center", "city": "Omaha", "state": "Nebraska", "zip": "63198", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "Newark Beth Israel Medical Center", "city": "Newark", "state": "New Jersey", "zip": "07112", "country": "United States", "geoPoint": {"lat": 40.73566, "lon": -74.17237}}, {"facility": "Montefiore Medical Center", "city": "Bronx", "state": "New York", "zip": "10467", "country": "United States", "geoPoint": {"lat": 40.84985, "lon": -73.86641}}, {"facility": "Mt. Sinai Medical Center", "city": "New York", "state": "New York", "zip": "10029", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "Columbia University Medical Center", "city": "New York", "state": "New York", "zip": "10032", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "University of Rochester Medical Center", "city": "Rochester", "state": "New York", "zip": "14642", "country": "United States", "geoPoint": {"lat": 43.15478, "lon": -77.61556}}, {"facility": "University of North Carolina at Chapel Hill", "city": "Chapel Hill", "state": "North Carolina", "zip": "27599", "country": "United States", "geoPoint": {"lat": 35.9132, "lon": -79.05584}}, {"facility": "Carolinas Medical Center", "city": "Charlotte", "state": "North Carolina", "zip": "28206", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"facility": "Duke University", "city": "Durham", "state": "North Carolina", "zip": "27710", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "University Hospitals of Cleveland", "city": "Cleveland", "state": "Ohio", "zip": "44106", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "Cleveland Clinic Foundation", "city": "Cleveland", "state": "Ohio", "zip": "44195", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "Ohio State University Medical Center", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "INTEGRIS Baptist Medical Center", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73112", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "Oregon Health and Science University", "city": "Portland", "state": "Oregon", "zip": "97239", "country": "United States", "geoPoint": {"lat": 45.52345, "lon": -122.67621}}, {"facility": "Hershey", "city": "Hershey", "state": "Pennsylvania", "zip": "17033", "country": "United States", "geoPoint": {"lat": 40.28592, "lon": -76.65025}}, {"facility": "Hospital of the University of Pennsylvania", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19104", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Thomas Jefferson University Hospital", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19107", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "Allegheny General Hospital", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15212", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "University of Pittsburgh Medical Center", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15323", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Medical University of South Carolina", "city": "Charleston", "state": "South Carolina", "zip": "29425", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "St. Thomas West Hospital", "city": "Nashville", "state": "Tennessee", "zip": "37205", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "Vanderbilt University Medical Center", "city": "Nashville", "state": "Tennessee", "zip": "37232", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "Baylor Research Institute", "city": "Dallas", "state": "Texas", "zip": "75246", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Memorial Hermann Health Systems", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Methodist Houston", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Texas Heart Institute", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "University of Utah Hospital and Clinics", "city": "Salt Lake City", "state": "Utah", "zip": "84132", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"facility": "University of Virginia Medical Center", "city": "Charlottesville", "state": "Virginia", "zip": "22908", "country": "United States", "geoPoint": {"lat": 38.02931, "lon": -78.47668}}, {"facility": "Inova Fairfax Hospital", "city": "Falls Church", "state": "Virginia", "zip": "22042", "country": "United States", "geoPoint": {"lat": 38.88233, "lon": -77.17109}}, {"facility": "Sentara Norfolk General Hospital", "city": "Norfolk", "state": "Virginia", "zip": "23507", "country": "United States", "geoPoint": {"lat": 36.84681, "lon": -76.28522}}, {"facility": "Bon Secours St. Mary's Hospital", "city": "Richmond", "state": "Virginia", "zip": "23226", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "Virginia Commonwealth University", "city": "Richmond", "state": "Virginia", "zip": "23298", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "University of Washington Medical Center", "city": "Seattle", "state": "Washington", "zip": "98195", "country": "United States", "geoPoint": {"lat": 47.60621, "lon": -122.33207}}, {"facility": "University of Wisconsin Hospitals and Clinics", "city": "Madison", "state": "Wisconsin", "zip": "53792", "country": "United States", "geoPoint": {"lat": 43.07305, "lon": -89.40123}}, {"facility": "St. Luke's Medical Center", "city": "Milwaukee", "state": "Wisconsin", "zip": "53215", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}]}, "referencesModule": {"references": [{"pmid": "27959709", "type": "BACKGROUND", "citation": "Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC Jr, Colombo PC, Walsh MN, Milano CA, Patel CB, Jorde UP, Pagani FD, Aaronson KD, Dean DA, McCants K, Itoh A, Ewald GA, Horstmanshof D, Long JW, Salerno C; MOMENTUM 3 Investigators. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 Feb 2;376(5):440-450. doi: 10.1056/NEJMoa1610426. Epub 2016 Nov 16."}, {"pmid": "36074476", "type": "DERIVED", "citation": "Mehra MR, Goldstein DJ, Cleveland JC, Cowger JA, Hall S, Salerno CT, Naka Y, Horstmanshof D, Chuang J, Wang A, Uriel N. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 Sep 27;328(12):1233-1242. doi: 10.1001/jama.2022.16197."}, {"pmid": "34525837", "type": "DERIVED", "citation": "Sheikh FH, Ravichandran AK, Goldstein DJ, Agarwal R, Ransom J, Bansal A, Kim G, Cleveland JC, Uriel N, Sheridan BC, Chomsky D, Patel SR, Dirckx N, Franke A, Mehra MR. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial. Circ Heart Fail. 2021 Oct;14(10):e008360. doi: 10.1161/CIRCHEARTFAILURE.120.008360. Epub 2021 Sep 16."}, {"pmid": "32740125", "type": "DERIVED", "citation": "Lundgren SW, Florescu DF, Zolty R. Reactivation of Cytomegalovirus Following Left Ventricular Assist Device Implantation: A Case-Control Study. ASAIO J. 2021 Apr 1;67(4):405-410. doi: 10.1097/MAT.0000000000001236."}, {"pmid": "32340871", "type": "DERIVED", "citation": "Saeed O, Colombo PC, Mehra MR, Uriel N, Goldstein DJ, Cleveland J, Connors JM, Najjar SS, Mokadam NA, Bansal A, Crandall DL, Sood P, Jorde UP. Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study. J Heart Lung Transplant. 2020 Jun;39(6):518-525. doi: 10.1016/j.healun.2020.03.001. Epub 2020 Mar 20."}, {"pmid": "32276809", "type": "DERIVED", "citation": "Patel CB, Blue L, Cagliostro B, Bailey SH, Entwistle JW, John R, Thohan V, Cleveland JC Jr, Goldstein DJ, Uriel N, Su X, Somo SI, Sood P, Mehra MR. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 Aug;39(8):774-781. doi: 10.1016/j.healun.2020.03.002. Epub 2020 Mar 20."}, {"pmid": "31939996", "type": "DERIVED", "citation": "Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J, Ransom J, Itoh A, Uriel N, Cleveland JC Jr, Raval NY, Cogswell R, Suarez EE, Lowes BD, Kim G, Bonde P, Sheikh FH, Sood P, Farrar DJ, Mehra MR. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. JAMA Cardiol. 2020 Apr 1;5(4):411-419. doi: 10.1001/jamacardio.2019.5323."}, {"pmid": "30883052", "type": "DERIVED", "citation": "Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Aaronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ; MOMENTUM 3 Investigators. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 Apr 25;380(17):1618-1627. doi: 10.1056/NEJMoa1900486. Epub 2019 Mar 17."}, {"pmid": "30586698", "type": "DERIVED", "citation": "Colombo PC, Mehra MR, Goldstein DJ, Estep JD, Salerno C, Jorde UP, Cowger JA, Cleveland JC Jr, Uriel N, Sayer G, Skipper ER, Downey FX, Ono M, Hooker R Jr, Anyanwu AC, Givertz MM, Mahr C, Topuria I, Somo SI, Crandall DL, Horstmanshof DA. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation. 2019 Jan 8;139(2):155-168. doi: 10.1161/CIRCULATIONAHA.118.037231."}, {"pmid": "30245150", "type": "DERIVED", "citation": "Mehra MR, Salerno C, Naka Y, Uriel N, Cleveland JC, Horstmanshof D, Goldstein DJ; MOMENTUM 3 Investigators. A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 Nov;37(11):1281-1284. doi: 10.1016/j.healun.2018.08.011. Epub 2018 Aug 24. No abstract available."}, {"pmid": "29807933", "type": "DERIVED", "citation": "Mehra MR, Salerno C, Cleveland JC, Pinney S, Yuzefpolskaya M, Milano CA, Itoh A, Goldstein DJ, Uriel N, Gulati S, Pagani FD, John R, Adamson R, Bogaev R, Thohan V, Chuang J, Sood P, Goates S, Silvestry SC. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 Oct 30;138(18):1923-1934. doi: 10.1161/CIRCULATIONAHA.118.035722."}, {"pmid": "29526139", "type": "DERIVED", "citation": "Mehra MR, Goldstein DJ, Uriel N, Cleveland JC Jr, Yuzefpolskaya M, Salerno C, Walsh MN, Milano CA, Patel CB, Ewald GA, Itoh A, Dean D, Krishnamoorthy A, Cotts WG, Tatooles AJ, Jorde UP, Bruckner BA, Estep JD, Jeevanandam V, Sayer G, Horstmanshof D, Long JW, Gulati S, Skipper ER, O'Connell JB, Heatley G, Sood P, Naka Y; MOMENTUM 3 Investigators. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12;378(15):1386-1395. doi: 10.1056/NEJMoa1800866. Epub 2018 Mar 11."}, {"pmid": "29154131", "type": "DERIVED", "citation": "Goldstein DJ, Mehra MR, Naka Y, Salerno C, Uriel N, Dean D, Itoh A, Pagani FD, Skipper ER, Bhat G, Raval N, Bruckner BA, Estep JD, Cogswell R, Milano C, Fendelander L, O'Connell JB, Cleveland J; MOMENTUM 3 Investigators. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 Jan;37(1):7-14. doi: 10.1016/j.healun.2017.11.001. Epub 2017 Nov 3."}, {"pmid": "29153637", "type": "DERIVED", "citation": "Cowger JA, Naka Y, Aaronson KD, Horstmanshof D, Gulati S, Rinde-Hoffman D, Pinney S, Adatya S, Farrar DJ, Jorde UP; MOMENTUM 3 Investigators. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients. J Heart Lung Transplant. 2018 Jan;37(1):15-24. doi: 10.1016/j.healun.2017.10.019. Epub 2017 Oct 24."}, {"pmid": "28385948", "type": "DERIVED", "citation": "Uriel N, Colombo PC, Cleveland JC, Long JW, Salerno C, Goldstein DJ, Patel CB, Ewald GA, Tatooles AJ, Silvestry SC, John R, Caldeira C, Jeevanandam V, Boyle AJ, Sundareswaran KS, Sood P, Mehra MR. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23;135(21):2003-2012. doi: 10.1161/CIRCULATIONAHA.117.028303. Epub 2017 Apr 6."}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "Subjects were recruited at 69 study sites in the United States from 2014 to 2016.", "groups": [{"id": "FG000", "title": "HeartMate II (Intent-to-Treat)", "description": "Patients randomized to HeartMate II LVAS (control device)"}, {"id": "FG001", "title": "HeartMate 3 (Intent-to-Treat)", "description": "Patients randomized to HeartMate 3 LVAS"}], "periods": [{"title": "Randomization to Device Implant", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "comment": "Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II", "numSubjects": "512"}, {"groupId": "FG001", "comment": "Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3", "numSubjects": "516"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "Patients who underwent HeartMate II LVAS implant", "numSubjects": "505"}, {"groupId": "FG001", "comment": "Patients who underwent HeartMate 3 LVAS implant", "numSubjects": "515"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "1"}]}], "dropWithdraws": [{"type": "Withdrawn prior to implant", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "1"}]}]}, {"title": "Two Year Follow up Post-implant", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "505"}, {"groupId": "FG001", "numSubjects": "515"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "247"}, {"groupId": "FG001", "numSubjects": "289"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "258"}, {"groupId": "FG001", "numSubjects": "226"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "103"}, {"groupId": "FG001", "numSubjects": "98"}]}, {"type": "Heart transplant", "reasons": [{"groupId": "FG000", "numSubjects": "137"}, {"groupId": "FG001", "numSubjects": "119"}]}, {"type": "Device explant or permanent deactivation", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "3"}]}, {"type": "Withdrawn post-implant", "reasons": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "6"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "HeartMate II (Intent-to-Treat)", "description": "Patients randomized to HeartMate II LVAS (control device)"}, {"id": "BG001", "title": "HeartMate 3 (Intent-to-Treat)", "description": "Patients randomized to HeartMate 3 LVAS"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "512"}, {"groupId": "BG001", "value": "516"}, {"groupId": "BG002", "value": "1028"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "60", "spread": "12"}, {"groupId": "BG001", "value": "59", "spread": "12"}, {"groupId": "BG002", "value": "60", "spread": "12"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "93"}, {"groupId": "BG001", "value": "105"}, {"groupId": "BG002", "value": "198"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "419"}, {"groupId": "BG001", "value": "411"}, {"groupId": "BG002", "value": "830"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Race or ethnic group", "categories": [{"title": "White", "measurements": [{"groupId": "BG000", "value": "367"}, {"groupId": "BG001", "value": "342"}, {"groupId": "BG002", "value": "709"}]}, {"title": "Black", "measurements": [{"groupId": "BG000", "value": "120"}, {"groupId": "BG001", "value": "145"}, {"groupId": "BG002", "value": "265"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "11"}]}, {"title": "Native Hawaiian or Pacific Islander", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "4"}]}, {"title": "Other", "measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "21"}, {"groupId": "BG002", "value": "39"}]}]}]}, {"title": "Ischemic Cause of Heart Failure", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "240"}, {"groupId": "BG001", "value": "216"}, {"groupId": "BG002", "value": "456"}]}]}]}, {"title": "History of Atrial Fibrillation", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "238"}, {"groupId": "BG001", "value": "215"}, {"groupId": "BG002", "value": "453"}]}]}]}, {"title": "History of Stroke", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "56"}, {"groupId": "BG001", "value": "50"}, {"groupId": "BG002", "value": "106"}]}]}]}, {"title": "Intended Goal of Support", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Bridge to transplantation", "measurements": [{"groupId": "BG000", "value": "121"}, {"groupId": "BG001", "value": "113"}, {"groupId": "BG002", "value": "234"}]}, {"title": "Bridge to candidacy for transplantation", "measurements": [{"groupId": "BG000", "value": "81"}, {"groupId": "BG001", "value": "86"}, {"groupId": "BG002", "value": "167"}]}, {"title": "Destination therapy", "measurements": [{"groupId": "BG000", "value": "310"}, {"groupId": "BG001", "value": "317"}, {"groupId": "BG002", "value": "627"}]}]}]}, {"title": "Inotropes", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "423"}, {"groupId": "BG001", "value": "445"}, {"groupId": "BG002", "value": "868"}]}]}]}, {"title": "Implantable cardioverter-defibrillator", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "382"}, {"groupId": "BG001", "value": "352"}, {"groupId": "BG002", "value": "734"}]}]}]}, {"title": "Intra-aortic balloon pump", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "79"}, {"groupId": "BG001", "value": "64"}, {"groupId": "BG002", "value": "143"}]}]}]}, {"title": "INTERMACS profile", "description": "INTERMACS profiles describe the clinical profile of advanced heart failure patients who may be candidates for mechanical circulatory support. There are 7 profiles ranging from Profile 1 (most sick) to Profile 7 (least sick). Profile 1 indicates critical cardiogenic shock. Profile 2 indicates progressive decline. Profile 3 indicates stable but inotrope dependent. Profile 4 indicates resting symptoms. Profile 5 indicates exertion intolerant. Profile 6 indicates exertion limited. Profile 7 indicates advanced NYHA Class 3 (clinically stable with a reasonable level of comfortable activity).", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "1", "measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "29"}]}, {"title": "2", "measurements": [{"groupId": "BG000", "value": "146"}, {"groupId": "BG001", "value": "156"}, {"groupId": "BG002", "value": "302"}]}, {"title": "3", "measurements": [{"groupId": "BG000", "value": "251"}, {"groupId": "BG001", "value": "272"}, {"groupId": "BG002", "value": "523"}]}, {"title": "4", "measurements": [{"groupId": "BG000", "value": "82"}, {"groupId": "BG001", "value": "67"}, {"groupId": "BG002", "value": "149"}]}, {"title": "5-7 or not provided", "measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "25"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Short Term Primary End Point", "description": "Survival at 6 months free of disabling stroke (Modified Rankin Score \\> 3) or reoperation to replace or remove a malfunctioning device", "populationDescription": "First 294 randomized Subjects", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "The first 294 randomized Subjects will be followed for 6 months or to outcome (transplant, explant, or death), whichever occurs first.", "groups": [{"id": "OG000", "title": "HeartMate II (Intent-to-Treat)", "description": "Patients randomized to HeartMate II LVAS (control device)"}, {"id": "OG001", "title": "HeartMate 3 (Intent-to-Treat)", "description": "Patients randomized to HeartMate 3 LVAS"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "142"}, {"groupId": "OG001", "value": "152"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "109"}, {"groupId": "OG001", "value": "131"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "NON_INFERIORITY", "nonInferiorityComment": "Non-inferiority would be demonstrated if the 95% lower confidence boundary for the difference between treatment groups (HM3 - HMII) in the occurrence of the primary end point would be greater than -10 percentage points, at a one-sided alpha level of 0.025 or a two-tailed P value of less than 0.05.", "pValue": "<0.001", "statisticalMethod": "Farrington-Manning risk difference", "paramType": "Risk Difference (RD)", "paramValue": "9.4", "ciPctValue": "95", "ciNumSides": "ONE_SIDED", "ciLowerLimit": "-2.1"}]}, {"type": "PRIMARY", "title": "Long Term Primary End Point", "description": "Survival at 2 years free of disabling stroke (Modified Rankin Score \\> 3) or reoperation to replace or remove a malfunctioning device", "populationDescription": "First 366 randomized Subjects", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "The first 366 randomized Subjects will be followed for 24 months or to outcome (transplant, explant, or death), whichever occurs first.", "groups": [{"id": "OG000", "title": "HeartMate II (Intent-to-Treat)", "description": "Patients randomized to HeartMate II LVAS (control device)"}, {"id": "OG001", "title": "HeartMate 3 (Intent-to-Treat)", "description": "Patients randomized to HeartMate 3 LVAS"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "176"}, {"groupId": "OG001", "value": "190"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "106"}, {"groupId": "OG001", "value": "151"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "NON_INFERIORITY", "nonInferiorityComment": "Non-inferiority would be demonstrated if the 95% lower confidence boundary for the difference between treatment groups (HM3 - HMII) in the occurrence of the primary end point would be greater than -10 percentage points, at a one-sided alpha level of 0.025 or a two-tailed P value of less than 0.05.", "pValue": "<0.001", "statisticalMethod": "Farrington-Manning risk difference", "paramType": "Risk Difference (RD)", "paramValue": "19.2", "ciPctValue": "95", "ciNumSides": "ONE_SIDED", "ciLowerLimit": "9.8"}]}, {"type": "SECONDARY", "title": "Powered Secondary End Point: Pump Replacement at Two Years", "description": "In addition to powering the study on the primary endpoints for PMA approval, the study will pre-specify a powered secondary endpoint to evaluate incidence of pump replacements at 24 months. HeartMate II is the control.", "populationDescription": "All subjects who underwent implant with the assigned device", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "As they occur up to 24 months or to Outcome, whichever occurs first", "groups": [{"id": "OG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device"}, {"id": "OG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "505"}, {"groupId": "OG001", "value": "515"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "57"}, {"groupId": "OG001", "value": "12"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Based on data in the Sponsor's device tracking database, 7% of patients with the HeartMate II LVAS receive a pump replacement by 24 months. The expected proportion of patients with the HeartMate 3 LVAS to receive a pump replacement by 24 months was assumed to be 3%. We estimated that to demonstrate superiority of HeartMate 3 to HeartMate II with a power of 80% and \u03b1 = 0.05 (2-sided), a total of 1028 patients (514 per arm) were required using the Fisher's exact test.", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Fisher Exact", "paramType": "Risk Ratio (RR)", "paramValue": "0.21", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": ".11", "ciUpperLimit": ".38"}]}, {"type": "SECONDARY", "title": "EuroQoL 5D-5L (EQ-5D-5L) Total Score", "description": "Quality of Life as measured by EuroQoL 5 Dimension-5 Level (EQ-5D-5L) total score. The EQ-5D-5L questionnaire has patients rate their quality of life across 5 categories of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scores from the 5 dimensions are summed for the total score which ranges from 5 to 25 with higher scores indicating more problems and a worse quality of life.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "Baseline to 24 months", "groups": [{"id": "OG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device"}, {"id": "OG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "505"}, {"groupId": "OG001", "value": "515"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "475"}, {"groupId": "OG001", "value": "486"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "11.2", "spread": "4.4"}, {"groupId": "OG001", "value": "11.1", "spread": "4.3"}]}]}, {"title": "6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "385"}, {"groupId": "OG001", "value": "418"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "8.5", "spread": "3.2"}, {"groupId": "OG001", "value": "8.5", "spread": "3.3"}]}]}, {"title": "24 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "227"}, {"groupId": "OG001", "value": "275"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "9.2", "spread": "3.8"}, {"groupId": "OG001", "value": "8.8", "spread": "3.6"}]}]}]}, {"type": "SECONDARY", "title": "EuroQol-5D-5L Visual Analogue Scale", "description": "Quality of life as measured by the visual analogue scale from the EuroQol-5D-5L questionnaire. The patient rates their current state of health with the visual analogue scale. The scale ranges from 0 to 100. Higher scores indicate a better quality of life.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "Baseline to 24 months", "groups": [{"id": "OG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device"}, {"id": "OG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "505"}, {"groupId": "OG001", "value": "515"}]}], "classes": [{"title": "Baselline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "475"}, {"groupId": "OG001", "value": "486"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "48", "spread": "25"}, {"groupId": "OG001", "value": "50", "spread": "24"}]}]}, {"title": "6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "386"}, {"groupId": "OG001", "value": "420"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "74", "spread": "19"}, {"groupId": "OG001", "value": "76", "spread": "18"}]}]}, {"title": "24 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "227"}, {"groupId": "OG001", "value": "276"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "75", "spread": "19"}, {"groupId": "OG001", "value": "76", "spread": "19"}]}]}]}, {"type": "SECONDARY", "title": "Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score", "description": "Quality of Life as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ). Scores range from 0 to 100. Higher scores indicate better quality of life and fewer heart failure symptoms.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "Baseline to 24 months", "groups": [{"id": "OG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device"}, {"id": "OG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "505"}, {"groupId": "OG001", "value": "515"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "482"}, {"groupId": "OG001", "value": "493"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "40", "spread": "23"}, {"groupId": "OG001", "value": "39", "spread": "20"}]}]}, {"title": "6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "388"}, {"groupId": "OG001", "value": "421"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "70", "spread": "21"}, {"groupId": "OG001", "value": "70", "spread": "20"}]}]}, {"title": "24 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "227"}, {"groupId": "OG001", "value": "277"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "68", "spread": "23"}, {"groupId": "OG001", "value": "69", "spread": "22"}]}]}]}, {"type": "SECONDARY", "title": "Six Minute Walk Test", "description": "Functional status as measured by the Six Minute Walk Test. The Six Minute Walk Test measures the distance a patient is able to walk during 6 minutes without running or jogging.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment. Patients unable to walk due to heart failure symptoms were assigned a distance of zero.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "meters", "timeFrame": "Baseline to 24 months", "groups": [{"id": "OG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device"}, {"id": "OG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "505"}, {"groupId": "OG001", "value": "515"}]}], "classes": [{"title": "Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "452"}, {"groupId": "OG001", "value": "471"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "129", "spread": "156"}, {"groupId": "OG001", "value": "136", "spread": "160"}]}]}, {"title": "6 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "333"}, {"groupId": "OG001", "value": "365"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "327", "spread": "136"}, {"groupId": "OG001", "value": "310", "spread": "142"}]}]}, {"title": "24 months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "174"}, {"groupId": "OG001", "value": "211"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "361", "spread": "337"}, {"groupId": "OG001", "value": "323", "spread": "156"}]}]}]}, {"type": "SECONDARY", "title": "New York Heart Association (NYHA) Classification", "description": "Functional status as measured by NYHA classification. NYHA class categorizes patients by the severity of their heart failure symptoms. As the class increases, the degree of symptoms is more severe indicating worse functional status. Class I indicates no limitation of physical activity. Class II indicates slight limitation of physical activity. Class IIIA indicates marked limitation of physical activity where less than ordinary physical activity causes fatigue, palpitation, dyspnea, or angina pain. Class IIIB indicates marked limitation of physical activity where mild physical activity causes fatigue, palpitation, dyspnea, or angina pain. Class IV indicates inability to carry on any physical activity without discomfort.", "populationDescription": "Analysis population only includes patients still ongoing on LVAD support at the specified time periods who completed the assessment", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline to 24 months", "groups": [{"id": "OG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device"}, {"id": "OG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "505"}, {"groupId": "OG001", "value": "515"}]}], "classes": [{"title": "Class I or II at Baseline", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "504"}, {"groupId": "OG001", "value": "514"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Class I or II at 6 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "392"}, {"groupId": "OG001", "value": "428"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "310"}, {"groupId": "OG001", "value": "340"}]}]}, {"title": "Class I or II at 24 Months", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "229"}, {"groupId": "OG001", "value": "275"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "176"}, {"groupId": "OG001", "value": "219"}]}]}]}, {"type": "SECONDARY", "title": "Rehospitalizations", "description": "Rate of all cause rehospitalization", "populationDescription": "Analysis population only includes Subjects who were discharged on LVAD support from the implant hospitalization", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "events per patient year", "timeFrame": "From initial discharge to two years post-implant", "groups": [{"id": "OG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device and were discharged on LVAD support"}, {"id": "OG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device and were discharged on LVAD support"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "471"}, {"groupId": "OG001", "value": "485"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.47"}, {"groupId": "OG001", "value": "2.26"}]}]}]}, {"type": "SECONDARY", "title": "Adverse Event Rates", "description": "Events-per-patient-year (EPPY) for anticipated adverse events as defined in the study protocol", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "events per patient year", "timeFrame": "Two years post-implant", "groups": [{"id": "OG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device"}, {"id": "OG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "505"}, {"groupId": "OG001", "value": "515"}]}], "classes": [{"title": "Arterial Non-CNS Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02"}, {"groupId": "OG001", "value": "0.01"}]}]}, {"title": "Bleeding", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.95"}, {"groupId": "OG001", "value": "0.61"}]}]}, {"title": "Cardiac Arrhythmia", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.45"}, {"groupId": "OG001", "value": "0.37"}]}]}, {"title": "Hepatic Dysfunction", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04"}, {"groupId": "OG001", "value": "0.03"}]}]}, {"title": "Hypertension", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08"}, {"groupId": "OG001", "value": "0.07"}]}]}, {"title": "Major Infection", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.82"}, {"groupId": "OG001", "value": "0.82"}]}]}, {"title": "Myocardial Infarction", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01"}, {"groupId": "OG001", "value": "0.01"}]}]}, {"title": "Stroke", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.18"}, {"groupId": "OG001", "value": "0.08"}]}]}, {"title": "Hemorrhagic Stroke", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07"}, {"groupId": "OG001", "value": "0.03"}]}]}, {"title": "Ischemic Stroke", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.11"}, {"groupId": "OG001", "value": "0.04"}]}]}, {"title": "Debilitating Stroke", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07"}, {"groupId": "OG001", "value": "0.04"}]}]}, {"title": "Other Neurological Event", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08"}, {"groupId": "OG001", "value": "0.09"}]}]}, {"title": "Pericardial Fluid Collection", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07"}, {"groupId": "OG001", "value": "0.04"}]}]}, {"title": "Psychiatric Episode", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.07"}, {"groupId": "OG001", "value": "0.08"}]}]}, {"title": "Renal Dysfunction", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.08"}, {"groupId": "OG001", "value": "0.11"}]}]}, {"title": "Respiratory Failure", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.17"}, {"groupId": "OG001", "value": "0.19"}]}]}, {"title": "Right Heart Failure", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.23"}, {"groupId": "OG001", "value": "0.27"}]}]}, {"title": "RVAD", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.03"}, {"groupId": "OG001", "value": "0.03"}]}]}, {"title": "Venous Thromboembolism", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.04"}, {"groupId": "OG001", "value": "0.04"}]}]}, {"title": "Wound Dehiscence", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.02"}, {"groupId": "OG001", "value": "0.01"}]}]}, {"title": "Suspected Device Thrombosis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.12"}, {"groupId": "OG001", "value": "0.01"}]}]}, {"title": "Hemolysis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.01"}, {"groupId": "OG001", "value": "0.01"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Two years post-implant", "eventGroups": [{"id": "EG000", "title": "HeartMate II (As-Treated)", "description": "Subjects randomized to HeartMate II LVAS who underwent implant with the assigned device", "deathsNumAffected": 103, "deathsNumAtRisk": 505, "seriousNumAffected": 466, "seriousNumAtRisk": 505, "otherNumAffected": 235, "otherNumAtRisk": 505}, {"id": "EG001", "title": "HeartMate 3 (As-Treated)", "description": "Subjects randomized to HeartMate 3 LVAS who underwent implant with the assigned device", "deathsNumAffected": 98, "deathsNumAtRisk": 515, "seriousNumAffected": 483, "seriousNumAtRisk": 515, "otherNumAffected": 261, "otherNumAtRisk": 515}], "seriousEvents": [{"term": "Arterial Non-CNS Thromboembolism", "organSystem": "Vascular disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 515}]}, {"term": "Bleeding", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 271, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 214, "numAtRisk": 515}]}, {"term": "Cardiac Arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 174, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 149, "numAtRisk": 515}]}, {"term": "Hepatic Dysfunction", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 23, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 20, "numAtRisk": 515}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 18, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 23, "numAtRisk": 515}]}, {"term": "Major Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 251, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 274, "numAtRisk": 515}]}, {"term": "Myocardial Infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 515}]}, {"term": "Stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 98, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 51, "numAtRisk": 515}]}, {"term": "Other Neurological Event", "organSystem": "Nervous system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 47, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 59, "numAtRisk": 515}]}, {"term": "Pericardial Fluid Collection", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 44, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 25, "numAtRisk": 515}]}, {"term": "Psychiatric Episode", "organSystem": "Psychiatric disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 24, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 31, "numAtRisk": 515}]}, {"term": "Renal Dysfunction", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 52, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 70, "numAtRisk": 515}]}, {"term": "Respiratory Failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 94, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 110, "numAtRisk": 515}]}, {"term": "Right Heart Failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 127, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 151, "numAtRisk": 515}]}, {"term": "Venous Thromboembolism", "organSystem": "Vascular disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 14, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 20, "numAtRisk": 515}]}, {"term": "Wound Dehiscence", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 515}]}, {"term": "Suspected Device Thrombosis", "organSystem": "Product Issues", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 70, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 515}]}, {"term": "Hemolysis", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 8, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 515}]}, {"term": "Other", "organSystem": "General disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 277, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 340, "numAtRisk": 515}]}], "otherEvents": [{"term": "Bleeding", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 26, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 31, "numAtRisk": 515}]}, {"term": "Cardiac Arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 46, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 54, "numAtRisk": 515}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 29, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 19, "numAtRisk": 515}]}, {"term": "Major Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 79, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 95, "numAtRisk": 515}]}, {"term": "Psychiatric Episode", "organSystem": "Psychiatric disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 21, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 24, "numAtRisk": 515}]}, {"term": "Right Heart Failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 19, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 28, "numAtRisk": 515}]}, {"term": "Other Adverse Event", "organSystem": "General disorders", "sourceVocabulary": "Study Protocol", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 113, "numAtRisk": 505}, {"groupId": "EG001", "numAffected": 139, "numAtRisk": 515}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "This was a non-blinded study"}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "MOMENTUM 3 has a study specific charter that governs the overall publication and presentation policy for all abstracts and manuscripts related to MOMENTUM 3 clinical data."}, "pointOfContact": {"title": "Joyce Chuang/Principal scientist", "organization": "Abbott", "email": "joyce.chuang@abbott.com", "phone": "925-353-5817"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2017-05-08", "uploadDate": "2019-09-25T11:39", "filename": "Prot_001.pdf", "size": 705322}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2016-01-22", "uploadDate": "2019-09-24T20:54", "filename": "SAP_000.pdf", "size": 566699}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M12154", "name": "Cardiomyopathies", "relevance": "LOW"}, {"id": "M20824", "name": "Ventricular Dysfunction", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}